Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
According to the Saxenda Summary of Product Characteristics (SmPC), treatment should be discontinued after 12 weeks on the 3.0 mg daily dose if patients have not lost at least 5% of their initial body weight
scRNA-seq analysis revealed high expression of advanced differentiation-stage markers, including those of secreted products ( PAEP , DEFB1 ), glands ( SCGB2A2 ) and ciliated cells ( FOXJ1 , PIFO ) (Fig
Hodges H, Fealko C, Soares N
PubMed laboratory research record [PMID: 30783379] PubMed record related to this compound for laboratory literature review
H.EvansR
US$ 24.90
US$ 23.81
US$ 26.71
US$ 24.43
US$ 29.49
US$ 28.65
US$ 23.37
